ADI vs FGEN · P/E 61, rev $11.02B vs rev $29.6M
Analog Devices Inc (ADI) versus FibroGen Inc (FGEN) — a side-by-side from cached financials, not a winner call.
Analog Devices Inc (ADI) is a semiconductors company listed on NASDAQ.
FibroGen Inc (FGEN) is a biotechnology company listed on NASDAQ.
Latest reported ADI revenue for 2025-11-01 was $11.02B. Net income was $2.27B. ADI currently screens at market cap $201.87B and trailing P/E 61.5.
Latest reported FGEN revenue for 2024-12-31 was $29.6M. Net income was -$47.6M. Revenue was down 36.7% from 2023-12-31 to 2024-12-31. FGEN currently screens at market cap $39.3M.
ADI currently screens at market cap $201.87B and trailing P/E 61.5. FGEN currently screens at market cap $39.3M.
Not investment advice. Open the ADI and FGEN stock pages for the full models.
Not investment advice.